{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:55:11Z","timestamp":1781373311788,"version":"3.54.1"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s00415-026-13902-1","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:22:18Z","timestamp":1780384938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mapping of motor and non-motor symptoms to 12-region dopamine transporter single-photon emission computed tomography in Parkinson\u2019s disease"],"prefix":"10.1007","volume":"273","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4659-2462","authenticated-orcid":false,"given":"Masakazu","family":"Ozawa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ami","family":"Yuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yoshimaru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4611-7098","authenticated-orcid":false,"given":"Hirotaka James","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"issue":"9996","key":"13902_CR1","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1016\/S0140-6736(14)61393-3","volume":"386","author":"LV Kalia","year":"2015","unstructured":"Kalia LV, Lang AE (2015) Parkinson\u2019s disease. Lancet 386(9996):896\u2013912","journal-title":"Lancet"},{"key":"13902_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2021.117476","volume":"426","author":"H Terashi","year":"2021","unstructured":"Terashi H et al (2021) Relationship between (123)I-FP-CIT-SPECT and motor severity in drug-naive patients with Parkinson\u2019s disease. J Neurol Sci 426:117476","journal-title":"J Neurol Sci"},{"key":"13902_CR3","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1038\/s41531-016-0006-9","volume":"3","author":"MA Qamar","year":"2017","unstructured":"Qamar MA et al (2017) Presynaptic dopaminergic terminal imaging and non-motor symptoms assessment of Parkinson\u2019s disease: evidence for dopaminergic basis? npj Parkinsons Dis 3:5","journal-title":"npj Parkinsons Dis"},{"key":"13902_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.sleep.2025.02.031","author":"M Ozawa","year":"2025","unstructured":"Ozawa M et al (2025) Putamen dopaminergic dysfunction is associated with sleep disturbance in drug-na\u00efve patients with Parkinson\u2019s disease. Sleep Med. https:\/\/doi.org\/10.1016\/j.sleep.2025.02.031","journal-title":"Sleep Med"},{"issue":"1","key":"13902_CR5","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.neuroimage.2010.06.044","volume":"54","author":"AC Tziortzi","year":"2011","unstructured":"Tziortzi AC et al (2011) Imaging dopamine receptors in humans with [11C]-(+)-PHNO: dissection of D3 signal and anatomy. Neuroimage 54(1):264\u2013277","journal-title":"Neuroimage"},{"issue":"supplement 2","key":"13902_CR6","first-page":"1928","volume":"57","author":"R Gunn","year":"2016","unstructured":"Gunn R, Coello C, Searle G (2016) Molecular imaging and kinetic analysis toolbox (MIAKAT) - a quantitative software package for the analysis of PET neuroimaging data. J Nucl Med 57(supplement 2):1928\u20131928","journal-title":"J Nucl Med"},{"issue":"11","key":"13902_CR7","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1212\/WNL.56.11.1559","volume":"56","author":"M Guttman","year":"2001","unstructured":"Guttman M et al (2001) Influence of l-dopa and pramipexole on striatal dopamine transporter in early PD. Neurology 56(11):1559\u20131564","journal-title":"Neurology"},{"issue":"4","key":"13902_CR8","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.pneurobio.2011.09.005","volume":"95","author":"K Marek","year":"2011","unstructured":"Marek K, Jennings D, Lasch S, Siderowf A, Tanner C, Simuni T et al (2011) The Parkinson Progression Marker Initiative (PPMI). Prog Neurobiol 95(4):629\u2013635. https:\/\/doi.org\/10.1016\/j.pneurobio.2011.09.005","journal-title":"Prog Neurobiol"},{"issue":"5","key":"13902_CR9","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417","journal-title":"Lancet Neurol"},{"issue":"15","key":"13902_CR10","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1002\/mds.22340","volume":"23","author":"CG Goetz","year":"2008","unstructured":"Goetz CG et al (2008) Movement Disorder Society-sponsored revision of the Unified Parkinson\u2019s Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov Disord 23(15):2129\u20132170","journal-title":"Mov Disord"},{"issue":"4","key":"13902_CR11","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1111\/j.1532-5415.2005.53221.x","volume":"53","author":"ZS Nasreddine","year":"2005","unstructured":"Nasreddine ZS et al (2005) The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695\u2013699","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"13902_CR12","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0031-9384(84)90269-5","volume":"32","author":"RL Doty","year":"1984","unstructured":"Doty RL, Shaman P, Dann M (1984) Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav 32(3):489\u2013502","journal-title":"Physiol Behav"},{"issue":"10","key":"13902_CR13","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1002\/mds.22571","volume":"24","author":"D Weintraub","year":"2009","unstructured":"Weintraub D et al (2009) Validation of the questionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease. Mov Disord 24(10):1461\u20131467","journal-title":"Mov Disord"},{"issue":"1","key":"13902_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0022-3956(82)90033-4","volume":"17","author":"JA Yesavage","year":"1982","unstructured":"Yesavage JA et al (1982) Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 17(1):37\u201349","journal-title":"J Psychiatr Res"},{"issue":"Suppl 11(0 11)","key":"13902_CR15","first-page":"S467","volume":"63","author":"LJ Julian","year":"2011","unstructured":"Julian LJ (2011) Measures of anxiety: state-trait anxiety inventory (STAI), Beck anxiety inventory (BAI), and hospital anxiety and depression scale-anxiety (HADS-A). Arthritis Care Res (Hoboken) 63(Suppl 11(0 11)):S467\u2013S472","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"6","key":"13902_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","volume":"14","author":"MW Johns","year":"1991","unstructured":"Johns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14(6):540\u2013545","journal-title":"Sleep"},{"issue":"16","key":"13902_CR17","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1002\/mds.21740","volume":"22","author":"K Stiasny-Kolster","year":"2007","unstructured":"Stiasny-Kolster K et al (2007) The REM sleep behavior disorder screening questionnaire\u2013a new diagnostic instrument. Mov Disord 22(16):2386\u20132393","journal-title":"Mov Disord"},{"issue":"11","key":"13902_CR18","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1002\/mds.20153","volume":"19","author":"M Visser","year":"2004","unstructured":"Visser M et al (2004) Assessment of autonomic dysfunction in Parkinson\u2019s disease: the SCOPA-AUT. Mov Disord 19(11):1306\u20131312","journal-title":"Mov Disord"},{"issue":"4","key":"13902_CR19","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1002\/ana.78116","volume":"99","author":"Z Fan","year":"2026","unstructured":"Fan Z et al (2026) Toward harmonizing quantification of dopamine neuron imaging biomarkers in Parkinson\u2019s disease: the Centamine scale. Ann Neurol 99(4):949\u2013963","journal-title":"Ann Neurol"},{"key":"13902_CR20","doi-asserted-by":"crossref","unstructured":"Ozawa, M., et al., (2026) DAT-SPECT-based subtype and stage inference in Parkinson\u2019s disease. NPJ Parkinsons Dis","DOI":"10.1038\/s41531-026-01347-2"},{"issue":"1","key":"13902_CR21","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1002\/acn3.268","volume":"3","author":"V Kaasinen","year":"2016","unstructured":"Kaasinen V (2016) Ipsilateral deficits of dopaminergic neurotransmission in Parkinson\u2019s disease. Ann Clin Transl Neurol 3(1):21\u201326","journal-title":"Ann Clin Transl Neurol"},{"key":"13902_CR22","doi-asserted-by":"publisher","first-page":"29","DOI":"10.5334\/tohm.712","volume":"12","author":"AH Abusrair","year":"2022","unstructured":"Abusrair AH, Elsekaily W, Bohlega S (2022) Tremor in Parkinson\u2019s disease: from pathophysiology to advanced therapies. Tremor Other Hyperkinet Mov (N Y) 12:29","journal-title":"Tremor Other Hyperkinet Mov (N Y)"},{"issue":"3","key":"13902_CR23","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00702-006-0518-2","volume":"114","author":"J Spiegel","year":"2007","unstructured":"Spiegel J et al (2007) Striatal FP-CIT uptake differs in the subtypes of early Parkinson\u2019s disease. J Neural Transm 114(3):331\u2013335","journal-title":"J Neural Transm"},{"issue":"1","key":"13902_CR24","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1136\/jnnp.2006.113860","volume":"79","author":"B Westermann","year":"2008","unstructured":"Westermann B et al (2008) Functional imaging of the cerebral olfactory system in patients with Parkinson\u2019s disease. J Neurol Neurosurg Psychiatry 79(1):19\u201324","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"19","key":"13902_CR25","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1212\/WNL.0000000000000960","volume":"83","author":"D Jennings","year":"2014","unstructured":"Jennings D et al (2014) Imaging prodromal Parkinson disease: the Parkinson associated risk syndrome study. Neurology 83(19):1739\u20131746","journal-title":"Neurology"},{"key":"13902_CR26","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.parkreldis.2018.02.048","volume":"51","author":"SJ Chung","year":"2018","unstructured":"Chung SJ et al (2018) Effect of striatal dopamine depletion on cognition in de novo Parkinson\u2019s disease. Parkinsonism Relat Disord 51:43\u201348","journal-title":"Parkinsonism Relat Disord"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13902-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T17:09:42Z","timestamp":1781370582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13902-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":26,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["13902"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13902-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"20 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional review boards of all participating sites and with the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All participants in the Parkinson\u2019s Progression Markers Initiative (PPMI) provided written informed consent at enrollment. The PPMI study was approved by the institutional review board at each participating site.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"352"}}